In view of the staggering statistics of women, especially menopausal women, who are affl icted with malignant breast tumors, there is an urgent need to seek eff ective measures to combat such sweeping health problems. Prominent species of medicinal mushrooms have a long-standing history of being used for health benefi ts, including antitumor eff ects, particularly in China, Japan, and Russia. We are examining bioactive polysaccharides and proteo-polysaccharides from selected species of medicinal mushrooms, in adjunct use with conventional cancer treatment. Our interest is in center therapy with immunoceuticals, imunomodulating components from medicinal mushrooms, which are eff ective by oral intake. Bioactive polysaccharides and proteo-polysaccharides in the category of imunoceuticals from Ganoderma lucidum (W.Curt.:Fr.) Lloyd, Grifola frondosa (Dicks.: Fr.) S.F.Gray, and Trametes versicolor (L.:Fr.)Pilát will be examined for their potential to alleviate the devastating side eff ects of conventional cancer treatments, such as presurgery hormonal therapy or chemotherapy to shrink the size of tumor, surgery, as well as postsurgery radiation therapy, chemotherapy, or hormonal therapy. Exciting initial results of a case study of a stage II breast cancer patient who uses bioactive polysaccharides from medicinal mushrooms during chemotherapy will be reported.
Th e project is designed as a forum to raise questions, evoke discussions, and seek evidence-based information. Th e intended audience is laymen at large and medical professionals, who are currently in practice. Sample questions in brainstorming include cell-receptor for glucans, autoimmune diseases, antioxidants, use of vitamin C, potential cross-drug interaction, toxicity, safety in use, contraindications, who should avoid using such components, and how can breast cancer patients benefi t.
To provide bioactive mushroom polysaccharide and proteo-polysaccharide in adjunct use to conventional cancer treatment is a vitally important area, to which medicinal mushroom science and industry can contribute. More quality large-scale longitudinal clinical studies as well as case studies with specifi c information are encouraged. Attention is called to mushroom growers to produce high-standard, organically grown mushrooms as a source of eff ective polysaccharides and proteo-polysaccharides with effi cacy for cancer and other uses.
